For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by injection, in preventing a repeat venous thromboembolism (VTE), ...

Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell Tumors Patients with advanced malignancy (N = 385) were randomly assigned ...

NEW YORK (MedscapeWire) Nov 30 — Pharmacia Corporation has initiated PREVENT (PRospective EValuation of Dalteparin Efficacy for Prevention of VTE in Immobilized PatieNts Trial) to study the safety and ...

Pfizer won the backing of a US Food and Drug Administration advisory panel yesterday to extend the use of its anti-clotting drug Fragmin to include the prevention of venous thromboembolism (VTE) in ...

For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by injection, in preventing a repeat venous thromboembolism (VTE), ...

The US Food and Drug Administration (FDA) approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in paediatric ...

Patients aged over 18 years with WHO performance status 0–2 and histologically proven advanced malignancy refractory to conventional treatment who gave written informed consent were eligible for the ...

Objective and Design: Tinzaparin and dalteparin are low molecular weight heparins (LMWHs) with different pharmacokinetic and pharmacodynamic profiles that may lead to differences in efficacy and ...

Thromboembol in blood vessel. Clot formation, 3D illustration Researchers sought to compare oral apixaban and subcutaneous dalteparin for treating patients with cancer-related venous thromboembolism.

Please provide your email address to receive an email when new articles are posted on . Extended treatment with oral edoxaban appeared comparable to subcutaneous dalteparin in safety and effectiveness ...